STOCK TITAN

My Size estimates less than 12 months of cash runway

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

My Size, Inc. (MYSZ) reported nine-month revenue of $7.322 million, up from $6.057 million, while nine-month net loss widened to $5.025 million from $2.845 million. Third-quarter revenue fell to $1.858 million from $2.572 million and net loss widened to $1.797 million from $1.335 million; the company attributed the quarterly revenue decline mainly to lower Amazon sales from reduced inventory.

Cash, cash equivalents and restricted cash totaled $2.412 million at September 30, 2026. Management said existing cash would fund operations for less than 12 months and disclosed substantial doubt about continued operations; operating cash use was $3.036 million. September financing included $2.117 million in net PIPE proceeds and $215,000 from an equity purchase agreement.

Naiz Fit reduced its workforce by approximately half; the company expects annualized savings of $793,000 and recorded about $255,000 in severance and related costs. MYSZ’s market value of listed securities was approximately $1 million on November 18, 2026, below the $5 million threshold contemplated by a Nasdaq rule whose effectiveness remained stayed pending SEC review.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 5 points

How the balance works

Positive

  • Moderate pointNine-month revenue rose to $7.322 million from $6.057 million.

Negative

  • Major pointNine-month net loss widened to $5.025 million from $2.845 million.
  • Major pointCash runway was less than 12 months, with substantial doubt about continued operations.
  • Moderate pointThird-quarter revenue fell to $1.858 million from $2.572 million.
  • Minor pointThird-quarter net loss widened to $1.797 million from $1.335 million.
  • Minor pointMarket value of listed securities was approximately $1 million on November 18, 2026, below the $5 million threshold contemplated by a Nasdaq rule whose effectiveness remained stayed pending SEC review.

Filing Explained

Completed financings have added common shares; further PIPE shares depend on warrant exercise.

The 10-Q records completed share sales under the ATM and equity purchase agreement and a closed PIPE; shares already issued increase the share count and reduce existing holders’ percentage ownership, while PIPE warrants leave additional share issuance conditional on exercise.

MYSZ reported 878,355 common shares outstanding at September 30, 2026, versus 579,973 at December 31, 2025; both figures reflect the reverse split. Under the equity purchase agreement, the company may—but is not required to—sell up to $10 million of shares over 36 months; by September 30 it had issued 94,421 shares for $215,000 and 33,654 commitment shares. The $10 million is facility capacity, not proceeds already received: purchases depend on the company delivering notices and satisfying the agreement’s conditions.

The PIPE closed on September 16, 2026 for $2.5 million gross and $2.117 million net proceeds, with 1,308,901 pre-funded warrants and Series C and Series D warrants for 1,308,901 shares each, plus placement-agent warrants for 91,623 shares. A pre-funded warrant is sold near the share price and converts into shares when exercised at its nominal exercise price. The PIPE resale registration became effective on October 7, 2026; registration does not itself mean the underlying warrant shares have been issued or sold. MYSZ said full cash exercise of all PIPE warrants would bring about $4.57 million, but gave no assurance that any would be exercised for cash.

Nine-month revenue $7.322 million vs. $6.057 million Nine months ended September 30, 2026 and 2025
Third-quarter revenue $1.858 million vs. $2.572 million Three months ended September 30, 2026 and 2025
Nine-month net loss $5.025 million vs. $2.845 million Nine months ended September 30, 2026 and 2025
Third-quarter net loss $1.797 million vs. $1.335 million Three months ended September 30, 2026 and 2025
Cash, cash equivalents and restricted cash $2.412 million As of September 30, 2026
Net cash used in operating activities $3.036 million vs. $2.806 million Nine months ended September 30, 2026 and 2025
Cash runway Less than 12 months Management’s estimate based on projected cash flows and balances as of September 30, 2026
Market value of listed securities Approximately $1 million As of November 18, 2026; below the $5 million threshold contemplated by a Nasdaq rule whose effectiveness remained stayed pending SEC review
going concern financial
"substantial doubt about our ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
At The Market Offering Agreement financial
"entered into an At The Market Offering Agreement"
An at-the-market offering agreement is a contract that lets a company sell newly issued shares directly into the open market through a broker, at whatever price the stock is trading at that moment. For investors this matters because it can increase the number of shares available (which may dilute existing ownership) while providing a flexible, often faster way for the company to raise cash without fixing a price, similar to a vendor selling small batches at current market stalls rather than setting a single fixed price.
Equity Purchase Agreement financial
"entered into an Equity Purchase Agreement with an investor"
An equity purchase agreement is a legal contract that sets the terms for buying ownership shares in a company, including the number of shares, price, and any conditions that must be met before the sale closes. For investors it matters because it determines how much ownership and control they gain, how the company’s value and share count change, and what protections or obligations each side has—think of it as the detailed bill of sale and ground rules for a stock purchase.
pre-funded warrants financial
"1,308,901 pre-funded warrants with an exercise price of $0.001 per share"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
fair value hierarchy financial
"Schedule of Significant Assets and Liabilities Measured at Fair Value on Recurring Basis"
Market Value of Listed Securities regulatory
"Market Value of Listed Securities (MVLS)"
Market value of listed securities is the market value of the shares a company has listed on an exchange, calculated as the closing bid price multiplied by the number of listed shares. Exchanges use it as a continued-listing standard, so a company that stays under the required minimum receives a deficiency notice and is given a set period to recover before facing delisting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much cash did MYSZ have, and what was its stated operating runway?

At September 30, 2026, it had $2.412 million in cash, cash equivalents and restricted cash. Management said existing cash would fund operations for less than 12 months and disclosed substantial doubt about the company’s ability to continue as a going concern.

How much did MYSZ raise in its September 2026 PIPE?

The PIPE generated approximately $2.5 million gross and $2.117 million net after $383,000 in issuance costs. It included 1,308,901 pre-funded warrants and accompanying Series C and Series D warrants, each for up to 1,308,901 shares; the Series C and D warrants are exercisable at $1.66 per share, subject to adjustment.

How many shares were registered for resale under MYSZ’s equity purchase agreement?

The registration covered resale of up to 3,252,404 common shares, including up to 3,125,000 shares that may be sold under the facility, 33,654 initial commitment shares and up to 93,750 true-up commitment shares. The registration statement was declared effective on August 12, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false Q3 --12-31 0001211805 0001211805 2026-01-01 2026-09-30 0001211805 2026-11-19 0001211805 2026-09-30 0001211805 2025-12-31 0001211805 2025-01-01 2025-09-30 0001211805 2026-07-01 2026-09-30 0001211805 2025-07-01 2025-09-30 0001211805 us-gaap:CommonStockMember 2025-12-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001211805 us-gaap:RetainedEarningsMember 2025-12-31 0001211805 us-gaap:CommonStockMember 2024-12-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001211805 us-gaap:RetainedEarningsMember 2024-12-31 0001211805 2024-12-31 0001211805 us-gaap:CommonStockMember 2026-06-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0001211805 us-gaap:RetainedEarningsMember 2026-06-30 0001211805 2026-06-30 0001211805 us-gaap:CommonStockMember 2025-06-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001211805 us-gaap:RetainedEarningsMember 2025-06-30 0001211805 2025-06-30 0001211805 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-09-30 0001211805 us-gaap:RetainedEarningsMember 2026-01-01 2026-09-30 0001211805 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-09-30 0001211805 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001211805 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-07-01 2026-09-30 0001211805 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001211805 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0001211805 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001211805 us-gaap:CommonStockMember 2026-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-09-30 0001211805 us-gaap:RetainedEarningsMember 2026-09-30 0001211805 us-gaap:CommonStockMember 2025-09-30 0001211805 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001211805 us-gaap:RetainedEarningsMember 2025-09-30 0001211805 2025-09-30 0001211805 MYSZ:AtTheMarketOfferingAgreementMember 2026-01-01 2026-09-30 0001211805 MYSZ:AtTheMarketOfferingAgreementMember 2025-01-01 2025-09-30 0001211805 MYSZ:AtTheMarketOfferingAgreementMember 2026-07-01 2026-09-30 0001211805 MYSZ:AtTheMarketOfferingAgreementMember 2025-07-01 2025-09-30 0001211805 2025-05-09 0001211805 MYSZ:ShareSaleAndPurchaseAgreementMember 2025-09-08 2025-09-08 0001211805 MYSZ:ShareSaleAndPurchaseAgreementMember us-gaap:CommonStockMember 2025-09-08 2025-09-08 0001211805 MYSZ:ShareSaleAndPurchaseAgreementMember 2025-09-08 0001211805 MYSZ:ShareSaleAndPurchaseAgreementMember us-gaap:CommonStockMember srt:MaximumMember 2025-09-08 0001211805 2026-03-02 2026-03-02 0001211805 2025-01-01 2025-01-31 0001211805 2026-08-12 2026-08-12 0001211805 MYSZ:EquityPurchaseAgreementMember 2026-01-01 2026-09-30 0001211805 us-gaap:CustomerRelationshipsMember srt:MinimumMember 2026-09-30 0001211805 us-gaap:CustomerRelationshipsMember srt:MaximumMember 2026-09-30 0001211805 MYSZ:TechnologyMember srt:MinimumMember 2026-09-30 0001211805 MYSZ:TechnologyMember srt:MaximumMember 2026-09-30 0001211805 us-gaap:TrademarksMember 2026-09-30 0001211805 MYSZ:SellingPlatformMember srt:MinimumMember 2026-09-30 0001211805 MYSZ:SellingPlatformMember srt:MaximumMember 2026-09-30 0001211805 us-gaap:FairValueInputsLevel1Member 2026-09-30 0001211805 us-gaap:FairValueInputsLevel2Member 2026-09-30 0001211805 us-gaap:FairValueInputsLevel3Member 2026-09-30 0001211805 us-gaap:FairValueInputsLevel1Member 2025-12-31 0001211805 us-gaap:FairValueInputsLevel2Member 2025-12-31 0001211805 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001211805 MYSZ:ResearchAndDevelopmentMember 2026-01-01 2026-09-30 0001211805 MYSZ:ResearchAndDevelopmentMember 2025-01-01 2025-09-30 0001211805 MYSZ:SalesAndMarketingMember 2026-01-01 2026-09-30 0001211805 MYSZ:SalesAndMarketingMember 2025-01-01 2025-09-30 0001211805 MYSZ:GeneralAndAdministrativeMember 2026-01-01 2026-09-30 0001211805 MYSZ:GeneralAndAdministrativeMember 2025-01-01 2025-09-30 0001211805 MYSZ:ResearchAndDevelopmentMember 2026-07-01 2026-09-30 0001211805 MYSZ:ResearchAndDevelopmentMember 2025-07-01 2025-09-30 0001211805 MYSZ:SalesAndMarketingMember 2026-07-01 2026-09-30 0001211805 MYSZ:SalesAndMarketingMember 2025-07-01 2025-09-30 0001211805 MYSZ:GeneralAndAdministrativeMember 2026-07-01 2026-09-30 0001211805 MYSZ:GeneralAndAdministrativeMember 2025-07-01 2025-09-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember 2026-09-30 0001211805 MYSZ:ShimonShukronMember 2024-07-01 2024-07-31 0001211805 2024-07-01 2024-07-31 0001211805 us-gaap:OperatingSegmentsMember MYSZ:FashionECommercePlatformMember 2026-01-01 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:SaasSolutionsMember 2026-01-01 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:ResalePlatformMember 2026-01-01 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:OthersMember 2026-01-01 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember 2026-01-01 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:FashionECommercePlatformMember 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:SaasSolutionsMember 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:ResalePlatformMember 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:OthersMember 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:FashionECommercePlatformMember 2025-01-01 2025-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:SaasSolutionsMember 2025-01-01 2025-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:ResalePlatformMember 2025-01-01 2025-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:OthersMember 2025-01-01 2025-09-30 0001211805 us-gaap:OperatingSegmentsMember 2025-01-01 2025-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:FashionECommercePlatformMember 2026-07-01 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:SaasSolutionsMember 2026-07-01 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:ResalePlatformMember 2026-07-01 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:OthersMember 2026-07-01 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember 2026-07-01 2026-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:FashionECommercePlatformMember 2025-07-01 2025-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:SaasSolutionsMember 2025-07-01 2025-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:ResalePlatformMember 2025-07-01 2025-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:OthersMember 2025-07-01 2025-09-30 0001211805 us-gaap:OperatingSegmentsMember 2025-07-01 2025-09-30 0001211805 us-gaap:OperatingSegmentsMember MYSZ:FashionECommercePlatformMember 2025-12-31 0001211805 us-gaap:OperatingSegmentsMember MYSZ:SaasSolutionsMember 2025-12-31 0001211805 us-gaap:OperatingSegmentsMember MYSZ:ResalePlatformMember 2025-12-31 0001211805 us-gaap:OperatingSegmentsMember MYSZ:OthersMember 2025-12-31 0001211805 us-gaap:OperatingSegmentsMember 2025-12-31 0001211805 MYSZ:MarketOfferingAgreementMember 2025-01-21 2025-01-21 0001211805 MYSZ:MarketOfferingAgreementMember 2026-01-01 2026-09-30 0001211805 MYSZ:MarketOfferingAgreementMember 2026-01-01 2026-06-30 0001211805 MYSZ:CapitalAdvanceAgreementMember 2026-01-27 0001211805 MYSZ:CapitalAdvanceAgreementMember 2026-01-27 2026-01-27 0001211805 MYSZ:CapitalAdvanceAgreementMember 2026-09-30 0001211805 us-gaap:CommonStockMember MYSZ:EquityPurchaseAgreementMember 2026-08-05 2026-08-05 0001211805 MYSZ:EquityPurchaseAgreementMember 2026-08-05 2026-08-05 0001211805 us-gaap:CommonStockMember MYSZ:EquityPurchaseAgreementMember 2026-08-12 2026-08-12 0001211805 MYSZ:EquityPurchaseAgreementMember 2026-07-01 2026-09-30 0001211805 us-gaap:PrivatePlacementMember 2026-09-15 0001211805 us-gaap:PrivatePlacementMember MYSZ:SeriesCWarrantsMember 2026-09-15 2026-09-15 0001211805 us-gaap:PrivatePlacementMember MYSZ:SeriesDWarrantsMember 2026-09-15 2026-09-15 0001211805 us-gaap:PrivatePlacementMember MYSZ:PreFundedWarrantAndSeriesCWarrantsAndSeriesDWarrantsMember 2026-09-15 0001211805 us-gaap:PrivatePlacementMember MYSZ:SeriesCWarrantsAndSeriesDWarrantsMember 2026-09-15 0001211805 us-gaap:PrivatePlacementMember 2026-09-15 2026-09-15 0001211805 us-gaap:SubsequentEventMember 2026-10-22 0001211805 us-gaap:SubsequentEventMember 2026-10-22 2026-10-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:ILS MYSZ:Segment iso4217:EUR iso4217:CHF

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______ to _______

 

Commission File No. 001-37370

 

MY SIZE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   51-0394637
(State or other jurisdiction   (I.R.S. Employer
of incorporation or organization)   I.D. No.)

 

HaNegev 4, POB 1026, Airport City, Israel, 7010000

(Address of principal executive offices)

 

+972-3-600-9030

Registrant’s telephone number, including area code:

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value per share   MYSZ   Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: as of November 19, 2026, 1,312,256 shares of common stock, par value $0.001 per share were issued and outstanding.

 

 

 

 
 

 

MY SIZE, INC.

INDEX TO QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2026

 

TABLE OF CONTENTS

 

    PAGE
PART I - FINANCIAL INFORMATION 1
     
Item 1. Condensed Consolidated Interim Financial Statements (Unaudited) 1
  Condensed Consolidated Interim Balance Sheets 3
  Condensed Consolidated Interim Statements of Comprehensive Loss 4
  Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity 5
  Condensed Consolidated Interim Statements of Cash Flows 6
  Notes to Condensed Consolidated Interim Financial Statements 7
Item 2. Management’s Discussion & Analysis of Financial Condition and Results of Operations 14
Item 3. Quantitative and Qualitative Disclosure About Market Risk 19
Item 4. Controls and Procedures 19
   
PART II - OTHER INFORMATION 20
   
Item 1. Legal Proceedings 20
Item 1A. Risk Factors 20
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 20
Item 3. Defaults Upon Senior Securities 20
Item 4. Mine Safety Disclosures 20
Item 5 Other information 20
Item 6. Exhibits 20

 

 
 

 

PART I

FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

My Size, Inc. and Subsidiaries

 

Condensed Consolidated

Interim

Financial Statements

As of September 30, 2026

(unaudited)

U.S. Dollars in Thousands

 

1
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Financial Statements as of September 30, 2026 (Unaudited)

 

Contents   Page
     
Condensed Consolidated Interim Balance Sheets (Unaudited)   3
     
Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)   4
     
Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity (Unaudited)   5
     
Condensed Consolidated Interim Statements of Cash flows (Unaudited)   6
     
Notes to Condensed Consolidated Interim Financial Statements (Unaudited)   7-13

 

2
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Balance Sheets (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

   September 30,   December 31, 
   2026   2025 
         
Assets          
Current Assets:          
Cash and cash equivalents   2,282    2,303 
Restricted cash   130    254 
Inventory   1,302    3,034 
Account receivables   866    1,214 
Other receivables and prepaid expenses   535    935 
Total current assets   5,115    7,740 
           
Property and equipment, net   82    110 
Operating right-of-use asset   82    106 
Intangible assets   1,190    1,596 
Goodwill   633    640 
Investment in marketable securities   2    2 
Other non-current asset   -    10 
Total non-current assets   1,989    2,464 
           
Total assets   7,104    10,204 
           
Liabilities and stockholders’ equity          
           
Current liabilities:          
Bank overdraft   1    - 
Operating lease liability   24    26 
Short-term loans   55    94 
Trade payables   602    2,221 
Liabilities to related parties   62    93 
Seller payables   191    251 
Provision for returns and deferred revenue   705    229 
Other payables   1,284    1,217 
Total current liabilities   2,924    4,131 
           
Loans and long-term contingencies   739    831 
Operating lease liability   67    85 
Total non-current liabilities   806    916 
Commitments and contingencies   -    - 
Total liabilities   3,730    5,047 
           
Stockholders’ equity:          
Stock Capital -          
Common stock of $0.001 par value - Authorized: 250,000,000 shares; Issued and outstanding: 878,355 and 579,973 as of September 30, 2026 and December 31, 2025, respectively*   1    1 
Additional paid-in capital   78,868    75,594 
Accumulated other comprehensive loss   (742)   (710)
Accumulated deficit   (74,753)   (69,728)
Total stockholders’ equity   3,374    5,157 
Total liabilities and stockholders’ equity   7,104    10,204 

 

* After giving effect to the reverse stock split, see also Note 1(c).

 

The accompanying notes are an integral part of the condensed consolidated interim financial statements.

 

3
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

                     
   Nine-Months Ended   Three-Months Ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
                 
Revenues   7,322    6,057    1,858    2,572 
Cost of revenues   (4,818)   (3,504)   (1,267)   (1,563)
Gross profit   2,504    2,553    591    1,009 
                     
Operating expenses                    
Research and development   (852)   (355)   (238)   (131)
Sales and marketing   (2,731)   (2,321)   (706)   (1,234)
General and administrative   (3,724)   (2,735)   (1,322)   (1,000)
Impairment of goodwill   -    (144)   -    - 
Total operating expenses   (7,307)   (5,555)   (2,266)   (2,365)
Operating loss   (4,803)   (3,002)   (1,675)   (1,356)
Financial income (expenses), net   (153)   157    (53)   21 
Other income (expenses), net   (69)   -    (69)   - 
Loss before taxes   (5,025)   (2,845)   (1,797)   (1,335)
                     
Net loss   (5,025)   (2,845)   (1,797)   (1,335)
Other comprehensive income (loss):                    
                     
Foreign currency translation differences   (32)   (36)   (82)   4 
                     
Total comprehensive loss   (5,057)   (2,881)   (1,879)   (1,331)
                     
Basic and diluted loss per share*   (7.01)   (8.02)   (1.90)   (3.22)
Basic and diluted weighted average number of shares outstanding*   716,516    354,694    943,578    414,196 

 

* After giving effect to the reverse stock split, see also Note 1(c)

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

4
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

               Accumulated         
           Additional   other       Total 
   Common stock***   paid-in   comprehensive   Accumulated   stockholders’ 
   Number   Amount   capital   loss   deficit   equity 
                         
Balance as of January 1, 2026   579,973    1    75,594    (710)   (69,728)   5,157 
Stock-based compensation related to options granted to employees and consultants   -    -    156    -    -    156 
Issuance of shares pursuant to At The Market Offering Agreement - net of $26 issuance cost**   170,513    -*   682    -    -    682 
Cancellation of fraction shares   (206)   -    -    -    -    - 
Issuance of shares and pre-funded warrants in private placement (PIPE), net of $383 issuance costs   -    -*   2,117    -    -    2,117 
Issuance of commitment shares pursuant to Equity Purchase Agreement   94,421    -*   215    -    -    215 
Issuance of shares as commitment fee under Equity Purchase Agreement   33,654    -*   104    -    -    104 
Total comprehensive loss   -    -    -    (32)   (5,025)   (5,057)
Balance as of September 30, 2026   878,355    1    78,868    (742)   (74,753)   3,374 

 

(*) Represents an amount less than $1.
(**) See note 7
(***) After giving effect to the reverse stock split, see also Note 1(c)

 

               Accumulated         
           Additional   other       Total 
   Common stock***   paid-in   comprehensive   Accumulated   stockholders’ 
   Number   Amount   capital   loss   deficit   equity 
                         
Balance as of January 1, 2025   255,020    1    71,609    (825)   (63,876)   6,909 
Stock-based compensation related to options granted to employees and consultants   1,250    -*   84    -    -    84 
Issuance of shares pursuant to At The Market Offering Agreement - net of $252 issuance cost**   194,716    -*   2,846    -    -    2,846 
Issuance of shares in connection with the acquisition of ShoeSizeMe (see Note 1(a))   30,137    -*   338    -    -    338 
Total comprehensive loss   -    -    -    (36)   (2,845)   (2,881)
Balance as of September 30, 2025   481,123    1    74,877    (861)   (66,721)   7,296 

 

(*) Represents an amount less than $1.
(**) See note 7
(***) After giving effect to the reverse stock split, see also Note 1(c)

 

               Accumulated         
           Additional   other       Total 
   Common stock*   paid-in   comprehensive   Accumulated   stockholders’ 
   Number   Amount   capital   loss   deficit   equity 
                         
Balance as of July 1, 2026   602,065    1    75,962    (660)   (72,956)   2,347 
Stock-based compensation related to options granted to employees and consultants   -    -    (22)   -    -    (22)
Issuance of shares pursuant to At The Market Offering Agreement - net of $19 issuance cost   148,215    -    492    -    -    492 
Issuance of shares and pre-funded warrants in private placement (PIPE), net of $383 issuance costs   -    -    2,117    -    -    2,117 
Issuance of commitment shares pursuant to Equity Purchase Agreement   94,421    -    215    -    -    215 
Issuance of shares as commitment fee under Equity Purchase Agreement   33,654    -    104    -    -    104 
Total comprehensive loss   -    -    -    (82)   (1,797)   (1,879)
Balance as of September 30, 2026   878,355    1    78,868    (742)   (74,753)   3,374 

 

(*) After giving effect to the reverse stock split, see also Note 1(c)

 

               Accumulated         
           Additional   other       Total 
   Common stock***   paid-in   comprehensive   Accumulated   stockholders’ 
   Number   Amount   capital   loss   deficit   equity 
                         
Balance as of July 1, 2025   387,885    1    73,664    (865)   (65,386)   7,414 
Stock-based compensation related to options granted to employees and consultants   -    -    16    -    -    16 
Issuance of shares pursuant to At The Market Offering Agreement - net of $37 issuance cost**   63,101    -*   859    -    -    859 
Issuance of shares in connection with the acquisition of ShoeSizeMe (see Note 1(a))   30,137    -*   338    -    -    338 
Total comprehensive loss   -    -    -    4    (1,335)   (1,331)
Balance as of September 30, 2025   481,123    1    74,877    (861)   (66,721)   7,296 

 

(*) Represents an amount less than $1
(**) See note 7
(***) After giving effect to the reverse stock split, see also Note 1(c)

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

5
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

U.S. dollars in thousands

 

   2026   2025 
  

Nine-Months Ended

September 30,

 
   2026   2025 
         
Cash flows from operating activities:          
Net loss   (5,025)   (2,845)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation   77    24 
Loss of control of subsidiary’s assets and liabilities due to insolvency   (85)   - 
Commitment fee settled in shares   104      
Change in operating lease right-of-use asset   26    9 
Amortization of intangible assets   369    226 
Impairment of goodwill   -    144 
Change in liabilities to related parties   (31)   (82)
Interest on long-term liabilities   26    - 
Interest paid   (26)   (6)
Revaluation of investment in marketable securities   -    (7)
Stock based compensation   156    84 
Change in inventory   1,732    (453)
Change in accounts receivable   348    (120)
Changes in operating lease liabilities   (19)   (10)
Change in other receivables and prepaid expenses   398    379 
Change in trade payables   (1,596)   (866)
Change in other payables   560    846 
Change in Seller payables   (60)   (119)
Change in other non-current asset   10    (10)
Net cash used in operating activities   (3,036)   (2,806)
           
Cash flows from investing activities:          
Purchase of property and equipment   (47)   (16)
Purchase of Percentil   -    (45)
Purchase of ShoeSizeMe, net of cash acquired   -    (142)
Proceeds from short-term deposits   -    7 
Net cash provided by (used in) investing activities   (47)   (196)
           
Cash flows from financing activities:          
Proceeds from issuance of shares, under At-The-Market offering, net   682    2,846 
Proceeds from issuance of pre-funded warrants in private placement, net   2,148      
Proceeds from issuance of shares under Equity Purchase Agreement   215      
Repayment of loans   (514)   (136)
Proceeds from loan   400    - 
           
Net cash provided by financing activities   2,931    2,710 
           
Effect of exchange rate fluctuations on cash and cash equivalents   7    (95)
Increase (decrease) in cash and cash equivalents   (145)   (387)
Cash and cash equivalents at the beginning of the period   2,557    4,880 
Cash and cash equivalents at the end of the period   2,412    4,493 
           
Cash and Cash Equivalents   2,282    4,493 
Restricted cash   130    - 
Cash, Cash Equivalents and Restricted Cash at end of the period   2,412    4,493 
           
Supplemental disclosure of Cash Flow Information:          
Cash paid for interest   26    6 
           
Supplemental disclosure of non-cash financing activities:          
Issuance of shares for the acquisition of ShoeSizeMe   -    338 
Issuance of commitment shares under Equity Purchase Agreement   104    - 
Accrued issuance costs – private placement   31    - 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

6
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 1 - General

 

  a. My Size, Inc. (the “Company”) is developing unique measurement technologies based on algorithms with applications focused on the apparel e-commerce market. The technology is driven by proprietary algorithms, which are able to calculate and record measurements in a variety of novel ways.

 

Following the acquisitions of Naiz Fit Bespoke Technologies, S.L (“Naiz” or “Naiz Fit’) in October 2022 and ShoeSize.Me AG (“ShoeSizeMe”) in September 2025, the Company expanded its offering outreach and customer base. Following the acquisition of Orgad International Marketing Ltd. (“Orgad”) in February 2022, the Company also operates an omnichannel e-commerce platform.

 

Following the formation of a new subsidiary, New Percentil S.L. (“New Percentil”), and acquisition of a new business unit in May 2025, the Company also operates a resale platform that enables consumers to buy and sell primarily secondhand apparel.

 

The Company has nine subsidiaries. My Size Israel 2014 Ltd. (“My Size Israel”), Topspin Medical (Israel) Ltd., Orgad and Rotrade Ltd., are all incorporated in Israel, My Size LLC, is incorporated in the Russian Federation, there are two limited liability companies incorporated under the laws of Spain namely Naiz Fit and New Percentil, and ShoeSizeMe, which is incorporated in Switzerland. On July 21, 2025, the Company established Ten Peacks Ltd. (“Ten Peacks”), which is incorporated in Israel and is a wholly-owned subsidiary of My Size Israel, that focuses on marketing and distribution of global apparel and shoes brands in Israel. References to the Company include the subsidiaries unless the context indicates otherwise.

 

My Size, Inc., was incorporated and commenced operations in September 1999, as Topspin Medical Inc. (“Topspin”), a private company registered in the State of Delaware. In December 2013, the Company changed its name to Knowledgetree Ventures Inc. Subsequently, in February 2014, the Company changed its name to My Size, Inc. Topspin was engaged, through its Israeli subsidiary, in research and development in the field of cardiology and urology.

 

On July 25, 2016, the Company’s common stock began publicly trading on the Nasdaq Capital Market under the symbol “MYSZ”.

 

On May 9, 2025, a newly-formed, wholly-owned subsidiary of the Company, New Percentil entered into a production unit transfer agreement with Casi Nuevo Kids, S.L., a limited liability company incorporated under the laws of Spain (“Casi Nuevo”), pursuant to which New Percentil acquired (the “Acquisition”) a production unit of Casi Nuevo with a trade name of Percentil that was judicially awarded to the Company in April 2025 within the framework of insolvency proceedings of Casi Nuevo filed with Commercial Court No. 13 of Madrid (Spain). The Acquisition was completed on May 9, 2025.

 

The Company paid for the total transaction an amount of €40 (approximately $45) cash payment and the assumption of certain customers, social security and debt liabilities. The Acquisition was financed through existing cash reserves and does not involve the issuance of additional shares or debt.

 

On September 8, 2025, the Company entered into a Share Sale and Purchase Agreement (the “Purchase Agreement”) with certain shareholders of ShoeSizeMe (the “Sellers”), who were the holders of 100% of the share capital of ShoeSizeMe, pursuant to which the Sellers sold to the Company all of the issued and outstanding shares of ShoeSizeMe. The acquisition of ShoeSizeMe closed on the same day. In consideration for the purchase of the shares of ShoeSizeMe and in accordance with the Purchase Agreement, the Company (i) paid a cash payment of $150 and (ii) issued 30,137 shares of the Company’s common stock. The fair value of the shares, for purposes of the purchase price allocation, was $338, determined based on the closing price of the Company’s common stock on September 8, 2025. In addition, pursuant to the Purchase Agreement, the Company issued to a key employee of ShoeSizeMe a warrant to purchase up to 3,500 shares of the Company’s common stock. In connection with the acquisition of ShoeSizeMe, certain major shareholders of ShoeSizeMe entered into (i) a voting agreement with the Company and (ii) customary six-month lock up agreements with the Company.

 

On June 23, 2026, as part of efficiency measures, the Company initiated voluntary insolvency proceedings of its subsidiary, ShoeSize. Me AG (“SSM”). The impact of the loss of control, net of the contingent liability recognized (see Note 5), was determined to be immaterial.

 

  b.

Since inception, the Company has incurred significant losses and negative cash flows from operations and has an accumulated deficit of $74,753. The Company’s management expects to continue generating losses and negative cash flows for the foreseeable future. If the Company’s plans to increase equity do not restore compliance with Nasdaq’s requirements by February 21, 2027, it may face delisting, which could make future fundraising more difficult. Based on projected cash flows and balances as of September 30, 2026, management believes existing cash will be sufficient to fund operations for less than 12 months, creating substantial doubt about the Company’s ability to continue as a going concern. Management’s plans to mitigate this include continuing product commercialization, acquiring technology or intellectual property, and securing financing through equity sales, debt, or strategic partnerships. However, there is no guarantee that additional funds will be available on acceptable terms or at all. If the Company fails to successfully commercialize its products or secure sufficient financing, it may be forced to cease operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Furthermore, on March 2, 2026, the Company received a formal deficiency notice letter from The Nasdaq Stock Market indicating that the Company is in violation of Nasdaq Listing Rule 5550(a)(2), as the closing bid price of our common stock fell below the minimum $1.00 per share threshold for 30 consecutive trading days. The Company was granted an initial compliance period until August 31, 2026 to regain compliance and, on August 12, 2026, effected a 1-for-8 reverse stock split (see Note 1c). On August 27, 2026, the Company received written notice from Nasdaq confirming that it had regained compliance with Nasdaq Listing Rule 5550(a)(2). In addition, on August 25, 2026, the Company received a letter from Nasdaq notifying the Company that its stockholders’ equity of $2,347 as of June 30, 2026 was below the minimum stockholders’ equity requirement of $2,500 under Nasdaq Listing Rule 5550(b)(1). The Company was required to submit a plan to regain compliance by October 9, 2026 and, if the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from the date of the letter, through February 21, 2027, to evidence compliance. The Company submitted its compliance plan on October 9, 2026 and is awaiting Nasdaq’s decision as of the date of this report. There is no guarantee the Company will meet Nasdaq’s continued listing standards. If the Company is delisted and ceases to be a publicly traded company, its ability to raise operational liquidity will be severely impaired, and it may be entirely unable to raise necessary funds through public capital markets. In addition, Nasdaq adopted a new continued listing rule requiring listed companies to maintain a minimum Market Value of Listed Securities (MVLS) of at least $5,000. However, on July 29, 2026, the SEC notified Nasdaq that it had received notices of intention to petition for review of the approval order and, pursuant to Rule 431(e) of the SEC’s Rules of Practice, the effectiveness of the approval order was automatically stayed pending further review by the SEC. As a result, the ultimate implementation, timing and scope of the MVLS requirement remains uncertain. If the rule goes into effect and the Company’s MVLS drops and remains below this $5,000 threshold for 30 consecutive business days, the Company will be subject to an immediate Staff Delisting Determination with no customary cure or compliance period. If the Company is delisted and ceases to be a publicly traded company, the Company’s ability to raise operational liquidity will be severely impaired, and it may be entirely unable to raise necessary funds through public capital markets

 

7
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 1 - General (Cont.)

 

In January 2025, the Company entered into an Offering Agreement with H.C. Wainwright & Co., LLC, as agent (“Wainwright”) pursuant to which it may offer and sell, from time to time through Wainwright shares of the Company’s common stock having an aggregate offering price of up to $4.1 million. The Company agreed to pay Wainwright a commission at a fixed rate of 3.0% of the aggregate gross proceeds from each sale of the shares under the Offering Agreement. As of the date hereof, the Company sold 399,705 shares (after giving effect to the reverse stock split, see also Note 1(c)) pursuant to the Offering Agreement for aggregate gross proceeds of approximately $4.1 million.

 

Stock split

 

  c. On July 21, 2026, the stockholders of the Company approved an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Company’s issued and outstanding common stock at a ratio ranging from 1-for-2 to 1-for-30, with the exact ratio to be determined by the Company’s board of directors. The board of directors subsequently approved a 1-for-8 reverse stock split, which became effective on August 12, 2026 with the shares beginning trading on a post-split basis on the Nasdaq Capital Market on August 13, 2026. All share and per share amounts for common stock, stock options and loss per share amounts have been adjusted to give retroactive effect to the reverse stock split for all periods presented in these financial statements.

 

  d. In late February 2026, Israel and the United States preemptively attacked Iran, in order to eliminate Iran’s nuclear and ballistic missile capabilities, and to target the Islamic fundamentalist regime governing Iran, which has threatened Israel’s existence. As part of this conflict, Iran launched missile attacks throughout Israel. This war followed similar conflicts in June 2025, and April 2024 and October 2024, during which Iran launched ballistic missile attacks against Israel, and Israel conducted strikes against Iranian military and nuclear infrastructure. The direct conflicts with Iran ran parallel to, and followed upon, a two-year war (from October 2023 until October 2025) during which Israel was attacked by Hamas and Hezbollah, terrorist groups sponsored by Iran operating out of the Gaza Strip and Lebanon, respectively. and declared war in response, which included ground operations in the Gaza Strip and southern Lebanon. Other Iranian sponsored terrorist organizations in the Middle East, including the Houthi terrorist group in Yemen, have also attacked Israel with various types of missiles and drones as part of these conflicts, and Israel has responded with airstrikes. On April 8, 2026, the United States and Iran agreed to a temporary ceasefire aimed at reaching a permanent agreement and ending the war. However, the ceasefire was repeatedly violated and ultimately collapsed in July 2026, and intermittent hostilities have continued. On April 16, 2026, Israel and Lebanon announced an initial ten-day cessation of hostilities, which was subsequently extended as the parties pursued negotiations toward a longer-term arrangement. Although the parties later agreed to a framework intended to advance lasting peace and security, violations and intermittent hostilities have continued, and the long-term stability and economic impact of these arrangements remain uncertain as of the reporting date.

 

The security situation in Israel has had an immaterial effect on its operations and financial results so far. This is attributable to its offices in Spain which has become a hub for the Company’s sizing solutions business. The majority of Orgad’s inventory utilizes fulfillment by Amazon rather than fulfilling directly. Inventory is now maintained and orders are shipped from regional Amazon warehouses, thereby reducing exposure to inventory risk and contributing to operating efficiencies. For the time being there is an effect on shipping costs that marginally affects the Company.

 

On February 24, 2022, Russia invaded Ukraine. The outbreak of hostilities between the two countries could result in more widespread conflict and could have a severe adverse effect on the region. Following Russia’s actions, various countries, issued broad-ranging economic sanctions against Russia. Such sanctions included, among other things, a prohibition on doing business with certain Russian companies, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications (SWIFT) electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions.

 

The Company shut down its operation in Russia and is expected to close down its subsidiary, My Size LLC, but due to technical reasons it is expected to occur in the near future. Therefore, the impact from the current situation is very limited.

 

8
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 2 - Significant Accounting Policies

 

  a. Unaudited condensed consolidated financial statements:

 

The accompanying unaudited condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”). The unaudited condensed consolidated financial statements are comprised of the financial statements of the Company and its subsidiaries. In management’s opinion, the interim financial data presented includes all adjustments necessary for a fair presentation. All intercompany accounts and transactions have been eliminated. Operating results for the nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for any future period or for the year ending December 31, 2026.

 

These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2025.

 

  b. Significant Accounting Policies:

 

The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements.

 

Equity Purchase Agreement

 

The Company evaluated the Equity Purchase Agreement (see Note 7(d)) under ASC 480, Distinguishing Liabilities from Equity, and ASC 815-40, Derivatives and Hedging – Contracts in Entity’s Own Equity. The Company’s right to require the investor to purchase shares of common stock (the “put right”) was determined to be a freestanding instrument that does not meet the conditions for equity classification, and its fair value at inception and as of September 30, 2026 was immaterial.

 

Shares of common stock issued to the investor as a commitment fee, and specific incremental legal and other costs directly attributable to the arrangement, are recorded as other expenses as they occur. In connection with the ELOC the company issued shares in a value of $104 to issuer as well as had legal expenses of $40 both were recorded as Other income (expense), net.

 

Intangible assets:

 

Intangible assets consist of identifiable intangible assets that the Company has acquired from previous business combinations. Intangible assets are recorded at costs, net of accumulated amortization. The Company amortizes its intangible assets reflecting the pattern in which the economic benefits of the intangible assets are consumed. When a pattern cannot be reliably determined, the Company uses a straight-line amortization method. Amortization is calculated by the straight-line method over the estimated useful lives of the following assets.

 

The estimated useful lives of the company’s intangible assets are as follows:

   years 
Customer Relationships   1-7 
Technology   2-5 
Trademark   5 
Selling Platform   2-5 

 

Each period, the Company evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.

 

Following structural changes in the SaaS business, the Company assessed the recoverability of its long-lived assets. Based on management’s revised forecast, the undiscounted cash flows are expected to exceed the carrying amount of the asset group; accordingly, no impairment is expected.

 

Loss per share

 

Pre-funded warrants are included in the weighted-average number of common shares outstanding for purposes of calculating basic earnings (loss) per share because their exercise price is nominal and all substantive conditions for exercise have been satisfied.

 

Note 3 – Financial Instruments

 

The carrying amounts of cash and cash equivalents, restricted cash, accounts receivable, other receivables, trade payables, accounts payable and short and long term loans approximate their fair value due to the short-term maturities of such instruments.

 

The Company holds share certificates My City Builders, Inc. (“MYCB”), formerly known as Diamante Minerals, Inc., a publicly traded company on the OTCQB.

 

Due to sales restrictions on the sale of the MYCB shares, the fair value of the shares was measured on the basis of the quoted market price for an otherwise identical unrestricted equity instrument of the same issuer that trades in a public market, adjusted to reflect the effect of the sales restrictions and is therefore, ranked as Level 2 assets.

 

   September 30, 2026 
   Fair value hierarchy 
   Level 1   Level 2   Level 3 
Financial assets               
                
Investment in marketable securities   -    2    - 

 

9
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 3 - Financial Instruments (Cont.)

 

    December 31, 2025  
    Fair value hierarchy  
    Level 1     Level 2     Level 3  
Financial assets                        
                         
Investment in marketable securities (*)     -       2       -  

 

(*) For the nine-month period and three months ended September 30, 2026, the Company did not recognize any gain on the revaluation of the marketable securities. For the nine-month period and three months ended September 30, 2025, the Company recognized a gain of $7 and $0, respectively (based on quoted market prices with a discount due to security restrictions on MYCB shares).

 

As the ELOC is in substance a purchased put option over the Company’s own shares at a price described in Note 7(d), the fair value of this agreement was approximately zero until the Company sold shares under the ELOC. Once the Company sold shares under the agreement, the difference between cash raised and the closing price of the Company’s common stock as of the date of their issuance was recognized as Other income (expense).

 

Fair value gain and losses arising from the ELOC are measured with reference to the spot price of the Company’s shares sold, less consideration receivable from the investor. 

 

Note 4 - Stock Based Compensation

 

The stock-based expense equity awards recognized in the financial statements for services received is related to Cost of Revenues, Research and Development, Sales and Marketing and General and Administrative expenses as shown in the following table:

 

       
   Nine months ended 
   September 30, 
   2026   2025 
Stock-based compensation expense - Research and development   25    19 
Stock-based compensation expense - Sales and marketing   6    4 
Stock-based compensation expense - General and administrative   125    61 
Stock-based compensation expense   156    84 

 

       
   Three months ended 
   September 30, 
   2026   2025 
Stock-based compensation expense - Research and development   (20)   5 
Stock-based compensation expense - Sales and marketing   (17)   - 
Stock-based compensation expense - General and administrative   15    11 
Stock-based compensation expense   (22)   16 

 

Stock Option Plan for Employees:

 

The total number of shares of common stock which may be granted to directors, officers and employees under the Company’s 2017 Equity Incentive Plan is limited to 123,585 shares.

 

During the nine months ended September 30, 2026, the Company granted 11,875 options. No options were granted during the three months ended September 30, 2026. During the nine months ended September 30, 2026, no options were exercised, and restricted shares granted in 2024 (second tranche) vested in January 1, 2026. No restricted or RSUs vested during the three months ended September 30, 2026.

 

During the nine and three month periods ended September 30, 2025, the Company did not grant any options, restricted stock and RSUs and no options were exercised.

 

The total stock option compensation expense for employees during the nine and three month periods ended September 30, 2026 and 2025 was $156, $(22), $84 and $16, respectively. The credit of $22 recorded during the three months ended September 30, 2026 reflects the reversal of share-based compensation expense recognized in excess during the three months ended June 30, 2026.

 

Note 5 - Contingencies and Commitments

 

In July 2024, the Company was served with a legal complaint filed by Shimon Shukron in the Magistrate’s Court in Herzliya (the “Court”) for a monetary award in an amount of NIS 1,895,345 (approximately $619). The plaintiff alleges that due to the fire that broke out at Orgad’s warehouse in January 2023, the fire spread to the plaintiff’s business and caused heavy damage to the structure and contents, inventory of the business and loss of profits. The Company filed its statement of defense in September 2024. At such preliminary stage, the plaintiff did not provide sufficient documents to support his claims regarding the extent of the alleged damage. In June 2025, the Court appointed a third-party appraiser to assess the damages. In August 2026, the Company and Shimon Shukron entered into an agreement pursuant to which the Company will pay NIS 425,000 in three monthly payments for all claims made (approximately $139), which agreement was approved by the Court. As of September 30, 2026, payments of NIS 200,000 (approximately $67) had been made under the settlement, and the remaining unpaid balance of NIS 225,000 (approximately $74) is recorded within current liabilities in the consolidated balance sheet. As of the date of this report, the liability has been paid in full.

 

Following the commencement of bankruptcy proceedings for SSM, management assessed the Group’s potential exposure in connection with SSM’s loan. According to the Company’s legal advisors, it is probable that creditors or the bankruptcy administrator could seek compensation in connection with the use of SSM’s certain assets which administrator may claim remain in the use of the group.

 

Based on management’s assessment and the legal opinion obtained, the Company recorded a contingent liability of CHF 600 (approximately $719) as of September 30, 2026. While the Company believes it has meritorious defenses against such claims, the ultimate resolution of the matter, which is not expected to occur within one year, could result in a loss of up to the amount assessed.

 

10
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 6 – Operating Segments

 

The Company has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel and (iv) others. This realignment reflects the way resources are allocated, and performance is assessed by the Chief Operating Decision Maker. The Fashion e-commerce platform which represents Orgad’s activity that was acquired by the Company in 2022, mainly operates on Amazon. The SaaS based innovative artificial intelligence driven measurement solutions, or SaaS Solutions operating segment consists of the Company and certain of its subsidiaries, My Size Israel, My Size LLC, Naiz and ShoeSizeMe (purchased in September 2025). The resale platform currently operates as a separate segment under New Percentil following the closing of the Acquisition in May 2025. The other segment currently operates under Ten Peacks.

 

The CODM reviews total operating expenses and consolidated net loss to assess performance, forecast future financial results, and allocate resources. In assessing the Company’s financial performance and making strategic decisions, the CODM regularly reviews segment operational loss and operating expenses by function. This includes a review of budget versus actual expenses and cost of goods, sales and marketing salaries, and other segment expenses. For the Fashion e-commerce platform operating segment, the CODM also reviews gross profit and Amazon fees. For the SaaS Solutions operating segment, the CODM also reviews research and development expenses.

 

Revenue, costs of goods and other costs and expenses are generally directly attributed to the segments. These expenses include research and development-related expenses, costs of Amazon fees, cost of goods, and legal-related costs. Indirect costs are allocated to segments based on a reasonable allocation methodology, when such costs are significant to the performance measures of the operating segments. Indirect operating expenses, such as insurance, legal, and audit services, are mostly allocated based on revenues, most of which is allocated to the Fashion e-commerce platform segment.

 

Information related to the operations of the Company’s reportable operating segments is set forth below:

 

   Fashion                 
   e-commerce   SaaS   Resale         
   platform   Solutions   Platform   Others   Total 
For the nine months ended September 30, 2026                         
Revenues from external customers   5,114    688    1,169    351    7,322 
Cost of revenues   (3,978)   (135)   (462)   (243)   (4,818)
Research and development expenses   (189)   (503)   (149)   (11)   (852)
Amazon fees   (1,147)   -    -    -    (1,147)
Sales and marketing salaries   (130)   (254)   -    (287)   (671)
Other Segment Items (*)   (1,792)   (1,133)   (1,331)   (381)   (4,637)
Segment loss   (2,122)   (1,337)   (773)   (571)   (4,803)
                          
Reconciliation of Profit or Loss                         
Financial income, (expense), net                       (153)
Other income (expense), net                       (69)
Loss before income taxes                       (5,025)
                          
Significant non-cash items:                         
Amortization   -    (236)   (133)   -    (369)
Share based payments   (140)   (16)   -    -    (156)

 

(*) Other segments items include share based payments, rent and related expenses, professional services, insurance and other expenses.

 

   Fashion                 
   e-commerce   SaaS   Resale         
   platform   Solutions   Platform   Others   Total 
As of September 30, 2026:                         
Assets   3,764    2,076    529    735    7,104 

 

   Fashion                 
   e-commerce   SaaS   Resale         
   platform   Solutions   Platform   Others   Total 
For the nine months ended September 30, 2025                         
Revenues from external customers   5,001    541    515    -    6,057 
Cost of revenues   (3,259)   (48)   (197)   -    (3,504)
Research and development expenses   -    (355)   -    -    (355)
Amazon fees   (1,478)   -    -    -    (1,478)
Sales and marketing salaries   (111)   (171)   -    (23)   (305)
Impairment of goodwill   (144)   -    -    -    (144)
Other Segment Items (*)   (1,834)   (809)   (630)   -    (3,273)
Segment loss   (1,825)   (842)   (312)   (23)   (3,002)
                          
Reconciliation of Profit or Loss                         
Financial income, (expense) net                       157 
Loss before income taxes                       (2,845)
                          
Significant non-cash items:                         
Amortization   (9)   (125)   (92)   -    (226)
Share based payments   (55)   (29)   -    -    (84)

 

(*) Other segments include shared based payments, rent and related expenses, professional services, insurance and other expenses.

 

11
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

   Fashion                 
   e-commerce   SaaS   Resale         
   platform   Solutions   Platform   Others   Total 
For the three months ended September 30, 2026                         
Revenues from external customers   1,083    240    413    122    1,858 
Cost of revenues   (895)   (43)   (199)   (130)   (1,267)
Research and development expenses   (34)   (154)   (49)   (1)   (238)
Amazon fees   (245)   -    -    -    (245)
Sales and marketing salaries   (38)   (95)   -    (74)   (207)
Other Segment Items (*)   (536)   (514)   (425)   (101)   (1,576)
Segment loss   (665)   (566)   (260)   (184)   (1,675)
                          
Reconciliation of Profit or Loss                         
Financial income, (expense), net                       (53)
Other income (expense), net                       (69)
Loss before income taxes                       (1,797)
                          
Significant non-cash items:                         
Amortization   -    (79)   (44)   -    (123)
Share based payments   20    2    -    -    22 

 

(*) Other segments items include share based payments, rent and related expenses, professional services, insurance and other expenses.

 

   Fashion                 
   e-commerce   SaaS   Resale         
   platform   Solutions   Platform   Others   Total 
For the three months ended September 30, 2025                         
Revenues from external customers   2,033    192    347    -    2,572 
Cost of revenues   (1,443)   (33)   (87)   -    (1,563)
Research and development expenses   -    (131)   -    -    (131)
Amazon fees   (757)   -    -    -    (757)
Sales and marketing salaries   (43)   (44)   -    (23)   (110)
Other Segment Items (*)   (573)   (315)   (479)   -    (1,367)
Segment loss   (783)   (331)   (219)   (23)   (1,356)
                          
Reconciliation of Profit or Loss                         
Financial income, (expense) net                       21 
Loss before income taxes                       (1,335)
                          
Significant non-cash items:                         
Amortization   -    (45)   (58)   -    (103)
Share based payments   (10)   (6)   -    -    (16)

 

(*) Other segments items include share based payments, rent and related expenses, professional services, insurance and other expenses.

 

   Fashion e-commerce platform   SaaS Solutions   Resale Platform   Others   Total 
As of December 31, 2025                         
Assets   6,733    2,455    626    390    10,204 

 

12
 

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 7 – Significant events during the reporting period.

 

  a. On January 21, 2025, the Company entered into an At The Market Offering Agreement (the “Offering Agreement”), with H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which the Company may offer and sell, from time to time through Wainwright shares of the Company’s common stock having an aggregate offering price of up to $4.1 million. The Company is not obligated to make any sales of the shares under the Offering Agreement. The offering of shares pursuant to the Offering Agreement will terminate upon the earliest of (a) the sale of all of the shares subject to the Offering Agreement and (b) the termination of the Offering Agreement by Wainwright or the Company, as permitted therein. The Company agreed to pay to Wainwright a cash commission of 3% of the gross sales price of any shares of common stock sold under the Offering Agreement. As of the date hereof, the Company sold 399,705 shares (after giving effect to the reverse stock split, see also Note 1(c)) pursuant to the Offering Agreement for aggregate gross proceeds of approximately $4.1 million, representing the full amount available for sale under the Offering Agreement.
     
  b. On January 27 2026, the Company entered into a Capital Advance agreement with Payoneer Inc. Under the terms of this arrangement, the Company received an upfront cash advancement of $400 in exchange for the commitment of future marketplace future sales. Payoneer automatically collects a contractually agreed-upon 21% of the Company’s gross daily marketplace payouts until the total face-value obligation of $424 is fully satisfied. The facility is non-compounding, features a single fixed capital fee of $24, and is structurally scheduled for full settlement within the current fiscal year. The Company determined that in accordance with ASC 470-10-25-2 that the agreement gives rise to a debt instrument. Consequently, in accordance with ASC 470 (Debt), the arrangement is accounted for as a Short term Loan and is classified within Current Liabilities on the Consolidated Balance Sheet. The fee of $24 is recorded over the term of the loan in the financial expenses in the consolidated Income statement. As of September 30, 2026, the loan had been repaid in full, the entire $24 fee had been recognized in financial expenses, and no balance remained outstanding in the consolidated balance sheet.

 

  c. During the three months ended September 30, 2026, the Company sold an aggregate of 148,215 shares (after giving effect to the reverse stock split, see also Note 1(c)) pursuant to the Offering Agreement with Wainwright, for gross proceeds of approximately $0.5 million ($492 net of issuance costs).
     
  d. On August 5, 2026, the Company entered into an Equity Purchase Agreement with an investor, pursuant to which, subject to the satisfaction of the conditions set forth therein, the Company has the right, but not the obligation, to sell to the investor, and the investor is obligated to purchase, up to $10.0 million of its common stock over a 36-month period. Purchases under the facility may be made from time to time at the Company’s discretion through the delivery of purchase notices, subject to certain conditions, limitations and the terms of the Equity Purchase Agreement. The purchase price for shares sold under the Equity Purchase Agreement will be determined pursuant to a formula based on the market price of our common stock during specified valuation periods. In consideration for the facility, the Company issued 33,654 shares of common stock to the investor as a commitment fee (the “Initial Commitment Shares”) and agreed to issue additional true-up commitment shares under certain circumstances given the condition was not met the company did not issue any top up share. In connection with the Equity Purchase Agreement, the Company filed a registration statement on Form S-1, which was declared effective by the SEC on August 12, 2026, covering the resale of up to 3,252,404 shares of common stock, consisting of up to 3,125,000 shares that may be sold under the facility, the 33,654 Initial Commitment Shares and up to 93,750 true-up commitment shares. During the three months ended September 30, 2026, the Company issued 94,421 shares of common stock under the Equity Purchase Agreement and received $215 from sales of shares under the Equity Purchase Agreement. The changes between the fair value of the shares issued were expensed in the income statement under Other income (expense).

 

  e.

On September 15, 2026, the Company entered into a securities purchase agreement with an institutional investor for a private placement (the “PIPE”), with H.C. Wainwright & Co., LLC acting as placement agent, of 1,308,901 pre-funded warrants with an exercise price of $0.001 per share (“pre-funded warrants”), together with Series C Warrants to purchase up to 1,308,901 shares of common stock and Series D Warrants to purchase up to 1,308,901 shares of common stock, at a combined purchase price of $1.91 per pre-funded warrant and accompanying Series C Warrant and Series D Warrant. The Series C Warrants and Series D Warrants are exercisable at $1.66 per share, subject to adjustment, and have terms of five (5) years and eighteen (18) months, respectively, commencing from the effective date of the underlying resale registration statement. The PIPE closed on September 16, 2026. In addition, the Company issued to the placement agent or its designees warrants to purchase up to 91,623 shares of common stock at an exercise price of $2.3875 per share, with a term of five (5) years from the effective date of the underlying resale registration statement. The total gross proceeds were approximately $2,500 and net proceeds were $2,117 after issuance costs of $383. The underlying resale registration statement was declared effective by the SEC on October 7, 2026.

 

Applying ASC 480 and ASC 815-40, the Company concluded that the warrants meet the conditions to be classified as permanent equity.

     
  f. In September 2026, as part of the Company’s efforts to streamline operations and reduce costs, Naiz implemented a workforce reduction affecting approximately half of its workforce. In connection with the workforce reduction, the Company booked severance and related costs of approximately $255, and are expected to be paid by August 2027. The workforce reduction did not result in any adjustment to the condensed consolidated interim financial statements as of and for the period ended September 30, 2026.

 

Note 8 – Subsequent events

 

  a.

On October 22, 2026, the Company’s board of directors, upon the recommendation of the Compensation Committee, approved the removal of Borja Cembrero Saralegui from his position as the Company’s Chief Growth Officer, effective October 31, 2026. Mr. Cembrero was also removed from his position as Executive Director of Naiz, effective as of the same date. In connection with his separation, the Company, Naiz and Mr. Cembrero entered into a Debt Acknowledgement and Payment Plan Agreement and a related confirmation letter, pursuant to which the Company and Naiz jointly and severally acknowledged an aggregate amount of approximately €433 (approximately $487) payable to Mr. Cembrero, consisting of severance compensation, payment in lieu of notice, accrued and unused vacation pay and €180 in consideration for a two-year post-termination non-competition covenant. Of such amount, €125 is payable in cash in monthly installments from November 2026 through August 2027, and the parties agreed to negotiate in good faith a payment plan for the remaining approximately €308, which may be satisfied in cash, in kind or through a combination thereof, including by the transfer of equity interests in an entity within the Company’s group. If the parties do not agree on such payment plan, the remaining balance will become due and payable on August 18, 2027.

     
  b. On November 8, 2026, management evaluated a plan to sell its ownership interest in New Percentil and began negotiations with a prospective purchaser. The proposed consideration is approximately €30 thousand, management is evaluating a deal. Management has agreed subject to terms to negotiate such deal during November 2026.

 

13
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis provides information that we believe to be relevant to an assessment and understanding of our results of operations and financial condition for the periods described. This discussion should be read together with our condensed consolidated interim financial statements and the notes to the financial statements, which are included in this Quarterly Report on Form 10-Q. This information should also be read in conjunction with the information contained in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission, or the SEC on April 15, 2026, or the Annual Report, including the consolidated annual financial statements as of December 31, 2025 and their accompanying notes included therein.

 

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended or the Exchange Act. Any statements in this Quarterly Report on Form 10-Q about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as “believe,” “will,” “expect,” “anticipate,” “estimate,” “intend,” “plan” and “would.” For example, statements concerning financial condition, possible or assumed future results of operations, growth opportunities, industry ranking, plans and objectives of management, markets for our common stock and future management and organizational structure are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement.

 

Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout this Quarterly Report on Form 10-Q. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to:

 

  ● our history of losses and needs for additional capital to fund our operations and our inability to obtain additional capital on acceptable terms, or at all;

 

  ● risks related to our ability to continue as a going concern;
     
  ● our ability to remain listed on Nasdaq;

 

  ● the new and unproven nature of the measurement technology markets;

 

  ● our ability to achieve customer adoption of our products;

 

  ● our ability to realize the benefits of our acquisitions of Orgad, Naiz, the Percentil production unit and ShoeSize.Me, and our ability to identify, finance and complete acquisitions of defense technology businesses in connection with our recently announced growth strategy;

 

  ● our ability to enhance our brand and increase market awareness;

 

  ● our ability to introduce new products and continually enhance our product offerings;

 

  ● the success of our strategic relationships with third parties;

 

  ● information technology system failures or breaches of our network security;

 

  ● competition from competitors;

 

  ● our reliance on key members of our management team;

 

  ● current or future litigation;

 

  ● current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk

 

  ● changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements and the impact of such policies on us, our customers and suppliers, and the global economic environment; and

 

  ● the impact of the political and security situation in Israel on our business.

 

14
 

 

The foregoing list sets forth some, but not all, of the factors that could affect our ability to achieve results described in any forward-looking statements. You should read this Quarterly Report on Form 10-Q and the documents that we reference herein and have filed as exhibits to the Quarterly Report on Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect. You should assume that the information appearing in this Quarterly Report on Form 10-Q is accurate as of the date hereof. Because the risk factors referred to on page 18 of our Annual Report, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of the information presented in this Quarterly Report on Form 10-Q, and particularly our forward-looking statements, by these cautionary statements.

 

Unless the context otherwise requires, all references to “we,” “us,” “our” or “the Company” in this Quarterly Report on Form 10-Q are to MySize, Inc., a Delaware corporation, and its subsidiaries, including MySize Israel 2014 Ltd., My Size LLC, Orgad International Marketing Ltd., or “Orgad”, Rotrade Ltd., Naiz Bespoke Technologies, S.L., or “Naiz Fit”, New Percentil S.L. or “New Percentil”, ShoeSize.Me AG or “ShoeSizeMe”, and Ten Peacks Ltd. or “Ten Peacks” taken as a whole.

 

References to “U.S. dollars” and “$” are to currency of the United States of America, and references to “NIS” are to New Israeli Shekels. Unless otherwise indicated, U.S. dollar translations of NIS amounts presented in this Quarterly Report on Form 10-Q for nine months ended on September 30, 2026 are translated using the rate of NIS 3.06 to $1.00.

 

All information in this Quarterly Report on Form 10-Q relating to shares or price per share reflects the 1-for-8 reverse stock split effected by us on August 12, 2026 with the shares beginning trading on a post-split basis on the Nasdaq Capital Market on August 13, 2026.

 

Overview

 

We are a fashion technology company operating an integrated portfolio of businesses designed to address the most pressing challenges facing fashion brands and retailers today—size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. Through our subsidiaries, we provide end-to-end support across the fashion value chain: Naiz Fit, our technology subsidiary, delivers AI-driven size and fit solutions for fashion e-commerce companies, and includes ShoeSize.Me, a European AI-powered footwear sizing solution we acquired in September 2025, which commenced voluntary insolvency proceedings in June 2026; Orgad, an online retailer and technology-enabled consumer products company operating principally as a third-party seller on Amazon; Percentil, a managed second-hand fashion recommerce platform operating across Southern and Central Europe; and Ten Peacks Ltd., a distribution subsidiary focused on marketing and distributing global apparel and footwear brands in Israel.

 

Our strategy is to build an integrated fashion platform—the infrastructure layer that enables fashion brands to address four critical pain points simultaneously: size and fit challenges that drive returns and suppress conversion rates; overstocked and unsold inventory that erodes margins; sustainability obligations that increasingly require brands to offer circular economy solutions; and international growth ambitions that require local distribution expertise and relationships.

 

We believe this integrated approach is differentiated in the market. Unlike point solutions that address a single problem, our platform is designed to allow brands to work with one group-level partner across technology, commerce, circularity, and distribution—each business unit reinforcing the others through shared data, commercial relationships, and infrastructure.

 

In September 2026, as part of our ongoing efforts to streamline operations and reduce costs, we implemented a workforce reduction at Naiz Fit, our technology subsidiary, which reduced its workforce by approximately half. We expect the workforce reduction to result in annualized cost savings of approximately $793. The workforce reduction may not result in the anticipated cost savings, and may adversely affect our ability to develop, support and commercialize our size and fit solutions.

 

In addition, on September 14, 2026, we announced an acquisition-led growth strategy focused on building a defense technology platform through the evaluation and potential acquisition of defense technology businesses over time. The strategy contemplates the selective pursuit of acquisition opportunities based on factors such as technology capabilities, commercial activity, customer relationships, growth prospects and financial profile, and would represent a diversification beyond our existing fashion technology and commerce operations. The implementation of this strategy remains subject to the identification of suitable acquisition targets, completion of due diligence, negotiation of definitive agreements, financing availability, and receipt of any required approvals. As of the date hereof, we have not entered into any definitive agreement with respect to any such acquisition.

 

Macroeconomic and Geopolitical Environment

 

Because we operate globally, our business is subject to the effects of economic downturns or recessions in the regions in which we do business, volatility in foreign currency exchange rates relative to the U.S. dollar, inflation, changing interest rates, expanded trade control laws and regulations, imposition of new or higher tariffs and geopolitical conflicts.

 

In addition, U.S. President Trump has made a series of announcements regarding the imposition of new and higher U.S. tariffs on imports from many countries. In response, certain countries, as well as the European Union, have announced retaliatory tariffs on imports of U.S. goods and other countermeasures. We are monitoring these actions, including any pauses, escalations, exemptions or removal of exemptions, with respect to the threatened or imposed tariffs, and will continue to assess their potential impact on our business either directly, such as on our hardware business, or due to downstream effects.

 

We also continuously monitor geopolitical conflicts around the world, including the ongoing conflict between Russia and Ukraine and conflicts in the Middle East, and assess their impact on our business. To date, these conflicts have not materially limited our ability to develop or support our products and have not had a material impact on our results of operations, financial condition, liquidity or cash flows.

 

While our business model provides some resilience against these factors, we will continue to monitor the direct and indirect impacts of these or similar circumstances on our business and financial results. For additional information on the potential impact of macroeconomic and geopolitical conditions on our business, see the “Risk Factors” section in our Annual Report.

 

15
 

 

Results of Operations

 

The table below provides our results of operations for the periods indicated.

 

   Nine-Months Ended   Three-Months Ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
                 
Revenues   7,322    6,057    1,858    2,572 
Cost of revenues   (4,818)   (3,504)   (1,267)   (1,563)
Gross profit   2,504    2,553    591    1,009 
Research and development expenses   (852)   (355)   (238)   (131)
Sales and marketing   (2,731)   (2,321)   (706)   (1,234)
General and administrative   (3,724)   (2,735)   (1,322)   (1,000)
Impairment of goodwill   -    (144)   -    - 
Operating loss   (4,803)   (3,002)   (1,675)   (1,356)
Financial income (expense), net   (153)   157    (53)   21 
Other income(expense), net   (69)   -    (69)   - 
Net loss   (5,025)   (2,845)   (1,797)   (1,335)

 

Nine and Three Months Ended September 30, 2026 Compared to Nine and Three Months Ended September 30, 2025

 

Revenues

 

Our revenues for the nine months ended September 30, 2026 amounted to $7,322,000 compared to $6,057,000 for the nine months ended September 30, 2025. The increase in the nine months ended September 30, 2026 from the corresponding period is primarily attributable to an increase in resale platform revenue as well as the inclusion of revenue generated by Ten Peacks in the consolidated report.

 

Our revenues for the three months ended September 30, 2026 amounted to $1,858,000 compared to $2,572,000 for the three months ended September 30, 2025. The decrease in the three months ended September 30, 2026 from the corresponding period is primarily attributable to lower Amazon sales resulting from reduced inventory levels.

 

Cost of Revenues

 

Our cost of revenues for the nine months ended September 30, 2026 amounted to $4,818,000 compared to $3,504,000 for the nine months ended September 30, 2025. The increase in cost of revenues was mainly attributable to lower gross margins of Orgad and Rotrade and to the inclusion of Ten Peacks in the consolidated results.

 

Our cost of revenues for the three months ended September 30, 2026 amounted to $1,267,000 compared to $1,563,000 for the three months ended September 30, 2025. The decrease in the three months ended September 30, 2026 from the corresponding period is primarily attributable to lower Amazon sales resulting from reduced inventory levels compared to the prior-year period.

 

Research and Development Expenses

 

Our research and development expenses for the nine months ended September 30, 2026 amounted to $852,000 compared to $355,000 for the nine months ended September 30, 2025. The increase from the corresponding period was mainly due to an increase in salaries expenses due to increased headcount and an increase in subcontractor expenses to align with our strategy to invest heavily in innovation.

 

Our research and development expenses for the three months ended September 30, 2026 amounted to $238,000 compared to $131,000 for the three months ended September 30, 2025. The increase was primarily due to an increase in subcontractor expenses and AI tools to align with our strategy to invest heavily in innovation. We expect the workforce reduction at Naiz Fit described under “Overview” above to reduce our research and development salary expenses in future periods.

 

Sales and Marketing Expenses

 

Our sales and marketing expenses for the nine months ended September 30, 2026 amounted to $2,731,000 compared to $2,321,000 for the nine months ended September 30, 2025. The increase was primarily attributable to marketing campaign of Naiz Fit and Percentil carried out in the first half of 2026.

 

Our sales and marketing expenses for the three months ended September 30, 2026 amounted to $706,000 compared to $1,234,000 for the three months ended September 30, 2025. The decrease was primarily attributable to lower Amazon fees in line with the decrease in Amazon sales.

 

16
 

 

General and Administrative Expenses

 

Our general and administrative expenses for the nine months ended September 30, 2026 amounted to $3,724,000 compared to $2,735,000 for the nine months ended September 30, 2025. The increase was attributable to the increase in consulting expenses for investor relations as well as the inclusion of Ten Peacks’ general and administrative expenses in the consolidated report.

 

Our general and administrative expenses for the three months ended September 30, 2026 amounted to $1,322,000 compared to $1,000,000 for the three months ended September 30, 2025. The increase was attributable to the inclusion of Ten Peacks’ general and administrative expenses in the consolidated report.

 

Operating Loss

 

As a result of the foregoing, for the nine months ended September 30, 2026, our operating loss was $4,803,000, an increase of $1,801,000, or 60%, compared to our operating loss for the nine months ended September 30, 2025 of $3,002,000.

 

As a result of the foregoing, for the three months ended September 30, 2026, our operating loss was $1,675,000, an increase of $319,000, or 24%, compared to our operating loss for the three months ended September 30, 2025 of $1,356,000.

 

Financial Income (Expense), Net

 

Our financial expense for the nine months ended September 30, 2026 was $153,000 as compared to financial income of $157,000 for the nine months ended September 30, 2025.

 

Our financial expense for the three months ended September 30, 2026 was $53,000 as compared to financial income of $21,000 for the three months ended September 30, 2025.

 

Other income (expense), net

 

Other expenses, net were $69,000 for both the nine and three months ended September 30, 2026, and consisted primarily of the commitment fee and legal costs related to the Equity Purchase Agreement, partially offset by a gain on the derecognition of the assets and liabilities of SSM, which is in insolvency proceedings and under the control of an administrator.

 

Net Loss

 

As a result of the foregoing, our net loss for the nine months ended September 30, 2026 was $5,025,000, compared to net loss of $2,845,000 for the nine months ended September 30, 2025. The increase in net loss was mainly due to the reasons mentioned above.

 

As a result of the foregoing, our net loss for the three months ended September 30, 2026 was $1,797,000, compared to net loss of $1,335,000 for the three months ended September 30, 2025. The increase in net loss was mainly due to the reasons mentioned above.

 

17
 

 

Liquidity and Capital Resources

 

Since our inception, we have funded our operations primarily through public and private offerings of debt and equity securities in the State of Israel and in the United States

 

As of September 30, 2026, we had cash, cash equivalents and restricted cash of $2,412,000, compared to $2,557,000 as of December 31, 2025, a decrease of $145,000. The decrease was primarily attributable to net cash used in operating activities of $3,036,000, including payments to suppliers and investments in the growth of our business, largely offset by total net proceeds from offerings of $3,045,000.

 

In January 2025, we entered into an At The Market Offering Agreement, or the Offering Agreement with H.C. Wainwright & Co., LLC, as agent, or Wainwright, pursuant to which we may offer and sell, from time to time through Wainwright shares of our common stock having an aggregate offering price of up to $4.1 million. We agreed to pay Wainwright a commission at a fixed rate of 3.0% of the aggregate gross proceeds from each sale of the shares under the Offering Agreement. As of the date hereof, we sold 399,705 (after giving effect to the reverse stock split, see also Note 1(c)) shares pursuant to the Offering Agreement for aggregate gross proceeds of approximately $4.1 million.

 

On August 5, 2026, we entered into an Equity Purchase Agreement with an investor, pursuant to which, subject to the satisfaction of the conditions set forth therein, we have the right, but not the obligation, to sell to the investor, and the investor is obligated to purchase, up to $10.0 million of our common stock over a 36-month period. Purchases under the facility may be made from time to time at our discretion through the delivery of purchase notices, subject to certain conditions, limitations and the terms of the Equity Purchase Agreement. The purchase price for shares sold under the Equity Purchase Agreement will be determined pursuant to a formula based on the market price of our common stock during specified valuation periods. In consideration for the facility, we issued 269,229 shares of common stock (33,654 shares after giving effect to the reverse stock split) to the investor as a commitment fee. In connection with the Equity Purchase Agreement, we filed a registration statement covering the resale of up to 3,252,404 shares of common stock, consisting of up to 3,125,000 shares that may be sold under the facility, the 33,654 initial commitment shares and up to 93,750 true-up commitment shares. During the three months ended September 30, 2026, we issued 94,421 shares of common stock and we received $215,000 from sales of shares under the Equity Purchase Agreement.

 

On September 15, 2026, we entered into a securities purchase agreement for the PIPE, pursuant to which we issued 1,308,901 pre-funded warrants, Series C Warrants to purchase up to 1,308,901 shares of common stock and Series D Warrants to purchase up to 1,308,901 shares of common stock, at a combined purchase price of $1.91 per pre-funded warrant and accompanying Series C Warrant and Series D Warrant. The PIPE closed on September 16, 2026, for net proceeds of $2,117,000 after issuance costs of $383,000, of which $31,000 were unpaid as of September 30, 2026. The Series C Warrants and Series D Warrants are exercisable at $1.66 per share. If all of the warrants issued in the PIPE, including the placement agent warrants, were exercised for cash in full, we would receive proceeds of approximately $4.57 million; however, there can be no assurance that any of such warrants will be exercised, or exercised for cash. In addition, subject to limited exceptions, we agreed not to effect or enter into an agreement to effect any variable rate transaction for a period of twelve months following the effective date of the resale registration statement, which may limit our financing alternatives. See Note 7(e) to our condensed consolidated interim financial statements.

 

Subsequent to September 30, 2026, in connection with the separation of our former Chief Growth Officer, we and Naiz acknowledged an aggregate obligation of approximately €433,000 (approximately $487,000), of which €125,000 is payable in monthly installments from November 2026 through August 2027. See Note 8 to our condensed consolidated interim financial statements.

 

In addition, in connection with the workforce reduction at Naiz Fit described under “Overview” above, we expect to pay severance and related costs of approximately $255,000.

 

Net cash used in operating activities was $3,036,000 for the nine months ended September 30, 2026, compared to $2,806,000 for the nine months ended September 30, 2025. Cash used in operating activities in 2026 primarily reflected our net loss of $5,025,000 and a $1,596,000 decrease in trade payables, partially offset by a $1,732,000 decrease in inventory and a $348,000 decrease in accounts receivable.

 

Net cash used by investing activities was $47,000 for the nine months ended September 30, 2026, representing the purchases of property and equipment of $47,000. This compares to net cash used in investing activities of $196,000 for the nine months ended September 30, 2025.

 

Net cash provided by financing activities was $2,931,000 for the nine months ended September 30, 2026, compared to $2,710,000 for the nine months ended September 30, 2025. Financing activities in 2026 consisted primarily of cash received of $2,148,000 from the PIPE, $682,000 from the ATM program and $215,000 from the Equity Purchase Agreement, as well as $400,000 of loan proceeds, partially offset by loan repayments of $514,000.

 

We expect that we will continue to generate losses and negative cash flows from operations for the foreseeable future. Based on the projected cash flows and cash balances as of September 30, 2026, management believes that our existing cash will be sufficient to fund operations for less than 12 months. As a result, there is substantial doubt about our ability to continue as a going concern. We will need to raise additional capital, which may not be available on reasonable terms or at all. Additional capital would be used to accomplish the following:

 

  ● finance our current operating expenses;

 

  ● pursue growth opportunities;

 

  ● hire and retain qualified management and key employees;

 

  ● respond to competitive pressures;

 

  ● comply with regulatory requirements; and

 

  ● maintain compliance with applicable laws.

 

Current conditions in the capital markets are such that traditional sources of capital may not be available to us when needed or may be available only on unfavorable terms. Our ability to raise additional capital, if needed, will depend on conditions in the capital markets, economic conditions, the security situation in Israel, and a number of other factors, many of which are outside our control, and on our financial performance. Accordingly, we cannot assure you that we will be able to successfully raise additional capital at all or on terms that are acceptable to us. If we cannot raise additional capital when needed, it may have a material adverse effect on our business, results of operations and financial condition.

 

To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of such securities could result in substantial dilution for our current stockholders. The terms of any securities issued by us in future capital-raising transactions may be more favorable to new investors, and may include preferences, superior voting rights and the issuance of warrants or other derivative securities, which may have a further dilutive effect on the holders of any of our securities then-outstanding. We may issue additional shares of our common stock or securities convertible into or exchangeable or exercisable for our common stock in connection with hiring or retaining personnel, option or warrant exercises, future acquisitions or future placements of our securities for capital-raising or other business purposes. The issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our common stock to decline and existing stockholders may not agree with our financing plans or the terms of such financings. In addition, we may incur substantial costs in pursuing future capital financing, including investment banking fees, legal fees, accounting fees, securities law compliance fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we issue, such as convertible notes and warrants, which may adversely impact our financial condition. Furthermore, any additional debt or equity financing that we may need may not be available on terms favorable to us, or at all. If we are unable to obtain such additional financing on a timely basis, we may have to curtail our development activities and growth plans and/or be forced to sell assets, perhaps on unfavorable terms, or we may have to cease our operations, which would have a material adverse effect on our business, results of operations and financial condition.

 

We have not entered into any transactions with unconsolidated entities in which we have financial guarantees, subordinated retained interests, derivative instruments or other contingent arrangements that expose us to material continuing risks, contingent liabilities or any other obligations under a variable interest in an unconsolidated entity that provides us with financing, liquidity, market risk or credit risk support.

 

18
 

 

Critical Accounting Estimates

 

Our management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which we have prepared in accordance with U.S. generally accepted accounting principles issued by the Financial Accounting Standards Board. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported expenses during the reporting periods. Actual results may differ from these estimates under different assumptions or conditions.

 

Our significant accounting policies were revenue from contracts with customers which are more fully described in the notes to our financial statements included herein. We believe these accounting policies are critical to our financial results and to the understanding of our past and future performance, as these policies relate to the more significant areas involving management’s estimates and assumptions. We consider an accounting estimate to be critical if: (1) it requires us to make assumptions because information was not available at the time or it included matters that were highly uncertain at the time we were making our estimate; and (2) changes in the estimate could have a material impact on our financial condition or results of operations.

 

Item 3. Quantitative and Qualitative Disclosure About Market Risk.

 

Not required for a smaller reporting company.

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act, and the rules and regulations thereunder, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

As required by Rule 13a-15(b) under the Exchange Act, our management, under the supervision and with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2026. Based upon such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of September 30, 2026 were effective.

 

Our Chief Executive Officer and Chief Financial Officer do not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

 

Changes in Internal Controls

 

During the most recent fiscal quarter, no change has occurred in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

19
 

 

Part II – Other Information

 

Item 1. Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

 

Shimon Shukron

 

In July 2024, the Company was served with a legal complaint filed by Shimon Shukron in the Magistrate’s Court in Herzliya (the “Court”) for a monetary award in an amount of NIS 1,895,345 (approximately $619). The plaintiff alleges that due to the fire that broke out at Orgad’s warehouse in January 2023, the fire spread to the plaintiff’s business and caused heavy damage to the structure and contents, inventory of the business and loss of profits. The Company filed its statement of defense in September 2024. At such preliminary stage, the plaintiff did not provide sufficient documents to support his claims regarding the extent of the alleged damage. In June 2025, the Court appointed a third-party appraiser to assess the damages. In August 2026, the Company and Shimon Shukron entered into an agreement pursuant to which the Company will pay NIS 425,000 in three monthly payments for all claims made (approximately $139), which agreement was approved by the Court.

 

As of September 30, 2026, payments of NIS 200,000 (approximately $67) had been made under the settlement, and the remaining unpaid balance of NIS 225,000 (approximately $74) is recorded within current liabilities in the consolidated balance sheet. As of the date of this report, the liability has been paid in full.

 

Item 1A. Risk Factors.

 

Except as set forth below in this Item 1A and the Risk Factors included in our previous filings made with the SEC, there have been no material changes to our risk factors from those disclosed in “Part I. Item 1A. Risk Factors” in the Company’s Annual Report on Form 10-K filed with the SEC on April 15, 2026.

 

If we fail to satisfy Nasdaq’s continued listing requirements, our common stock may be delisted from Nasdaq, which could adversely affect the liquidity and market price of our common stock and our ability to raise capital.

 

Nasdaq has established certain standards for the continued listing of a security on the Nasdaq Capital Market. The standards for continued listing include, among other things, that the minimum bid price for the listed securities not fall below $1.00 per share for a period of 30 consecutive trading days, that we maintain a minimum of $2,500,000 in shareholders’ equity and that our Market Value of Listed Securities (“MVLS”) not fall below $5.0 million for a period of 30 consecutive trading days, as further discussed below.

 

We have in the past fallen out of compliance with certain continued listing standards, including the minimum bid price requirement. On March 2, 2026, we received a deficiency notice from Nasdaq with respect to the minimum bid price requirement and, on August 12, 2026, we effected a 1-for-8 reverse stock split in order to regain compliance. On August 27, 2026, we received notice from Nasdaq that we had regained compliance with the minimum bid price requirement. In addition, on August 25, 2026, we received a letter from Nasdaq notifying us that our stockholders’ equity of $2,347,000 as of June 30, 2026, as reported in our Quarterly Report on Form 10-Q for such period, did not satisfy the $2,500,000 minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1). We were required to submit a plan to regain compliance by October 9, 2026 and, if the plan is accepted, Nasdaq may grant us an extension of up to 180 calendar days from the date of the letter, or through February 21, 2027, to evidence compliance. We submitted our compliance plan on October 9, 2026. There can be no assurance that Nasdaq will accept our plan or that we will be able to regain or maintain compliance with the stockholders’ equity requirement or any other continued listing requirement, including the minimum bid price requirement. No assurance, however, can be given that we will continue to be in compliance with the continued listing requirements of the Nasdaq Capital Market. Failure to meet applicable Nasdaq continued listing standards could result in a delisting of our common stock. A delisting of our common stock from Nasdaq could materially reduce the liquidity of our common stock and result in a corresponding material reduction in the price of our common stock. In addition, delisting could harm our ability to raise capital through alternative financing sources on terms acceptable to us, or at all, and may result in the potential loss of confidence by investors and employees and fewer business development opportunities.

 

On July 22, 2026, the SEC approved a new Nasdaq continued listing requirement applicable to companies listed on the Nasdaq Stock Market that would require listed companies to maintain a minimum MVLS of at least $5.0 million. Under the approved rule, if a company’s MVLS remains below $5.0 million for 30 consecutive business days, Nasdaq will issue a Staff Delisting Determination and immediately suspend trading in the company’s securities and commence delisting proceedings. Unlike many other Nasdaq continued listing standards, the rule does not provide a compliance or cure period before a delisting determination is issued. Although a company may appeal a delisting determination, the appeal generally does not stay the suspension of trading, and the company’s securities would generally trade on an over-the-counter market during the appeals process. In addition, any exception that may be granted by a Nasdaq Hearings Panel is limited. In particular, the Hearings Panel may grant an exception of up to 180 days only if the company demonstrates that it can satisfy Nasdaq’s applicable initial listing requirements, which are generally more stringent than Nasdaq’s continued listing standards. As a result, companies subject to a delisting determination under the MVLS rule may have fewer opportunities to regain compliance than under other Nasdaq continued listing requirements.

 

However, on July 29, 2026, the SEC notified Nasdaq that it had received notices of intention to petition for review of the approval order and, pursuant to Rule 431(e) of the SEC’s Rules of Practice, the effectiveness of the approval order was automatically stayed pending further review by the SEC. As a result, the ultimate implementation, timing and scope of the MVLS requirement remain uncertain. As of November 18, 2026, our MVLS was approximately $1 million, which is below the $5.0 million threshold contemplated by the rule. Accordingly, if the stay is lifted, the rule becomes effective and we are unable to satisfy the MVLS requirement, our securities would become subject to suspension and delisting from Nasdaq. Any such suspension or delisting could materially reduce the liquidity and market price of our common stock, impair our ability to raise additional capital, reduce investor interest in our securities and adversely affect our business, financial condition and prospects.

 

Our recently announced strategy to pursue acquisitions of defense technology businesses is subject to significant risks and uncertainties and may not be successfully implemented.

 

On September 14, 2026, we announced an acquisition-led growth strategy focused on building a defense technology platform through the evaluation and potential acquisition of defense technology businesses. We have limited operating experience in the defense technology sector. The implementation of this strategy is subject to, among other things, our ability to identify suitable acquisition targets, complete due diligence, negotiate and enter into definitive agreements on acceptable terms, obtain financing, and obtain any required Nasdaq, corporate, stockholder and regulatory approvals. Defense technology businesses may be subject to export controls, licensing requirements, government contracting regulations and other legal and regulatory restrictions with which we have limited experience. Any acquisitions may require us to issue equity or equity-linked securities, which could result in substantial dilution to our existing stockholders, and may divert management attention and resources from our existing businesses. We may be unable to integrate any acquired businesses successfully or realize the anticipated benefits of this strategy, and there can be no assurance that we will complete any acquisition.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Except as previously reported in our Current Reports on Form 8-K filed with the SEC on August 5, 2026 and September 16, 2026, we did not sell any equity securities that were not registered under the Securities Act during the quarter ended September 30, 2026.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

During the quarter ended September 30, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (in each case, as defined in Item 408 of Regulation S-K).

 

Item 6. Exhibits.

 

Exhibit    
Number   Description of Exhibits
3.1   Certificate of Amendment to Amended and Restated Certificate of Incorporation of My Size, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on August 12, 2026).
10.1   Form of Equity Purchase Agreement, dated August 5, 2026, between the Company and Square Gate Master Fund, LLC - Series 5 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on August 5, 2026).
10.2   Form of Registration Rights Agreement, dated August 5, 2026, between the Company and Square Gate Master Fund, LLC - Series 5 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on August 5, 2026).
10.3   Form of Securities Purchase Agreement, dated September 15, 2026 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 16, 2026).
10.4   Form of Series C and Series D Warrant (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on September 16, 2026).
10.5   Form of Pre-Funded Warrant (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on September 16, 2026).
10.6   Form of Placement Agent Warrant (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on September 16, 2026).
10.7   Form of Registration Rights Agreement, dated September 15, 2026 (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K filed with the SEC on September 16, 2026).
31.1*   Certification of Principal Executive Officer pursuant to 18 U.S.C Section 1350, as adopted Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*   Certification of Principal Executive Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*   Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Schema
101.CAL*   Inline XBRL Taxonomy Calculation Linkbase
101.DEF*   Inline XBRL Taxonomy Definition Linkbase
101.LAB*   Inline XBRL Taxonomy Label Linkbase
101.PRE*   Inline XBRL Taxonomy Presentation Linkbase
104*   Cover Page Interactive Data File (formatted as Inline XBRL document and contained in Exhibit 101)

 

* Filed herewith

 

20
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  My Size, Inc.
   
Date: November 19, 2026 By: /s/ Ronen Luzon
    Ronen Luzon
    Chief Executive Officer
    (Principal Executive Officer)
     
Date: November 19, 2026 By: /s/ Oren Elmaliah
    Oren Elmaliah
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

21


 

Keep reading